![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aevi Genomic Medicine Inc | NASDAQ:GNMX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.1659 | 0.1601 | 0.165 | 0 | 01:00:00 |
| |
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS
FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON September 10, 2019. The Proxy Statement and the 2018 Annual Report on Form 10-K are available for viewing, printing and downloading at www.proxyvote.com |
| |
Name
|
| |
Shares Beneficially Owned
|
| |||||||||
|
Number
|
| |
Percentage**
|
| ||||||||
5% Stockholders: | | | | ||||||||||
The Children’s Hospital of Philadelphia Foundation
(1)(6)
|
| | | | 21,311,586 | | | | | | 31.5 % | | |
Philip R. Harper
(2)
|
| | | | 4,924,819 | | | | | | 7.6 % | | |
Sol J. Barer
(3)
|
| | | | 4,943,664 | | | | | | 7.5 % | | |
Name
|
| |
Shares Beneficially Owned
|
| |||||||||
|
Number
|
| |
Percentage**
|
| ||||||||
Named Executive Officers and Directors: | | | | ||||||||||
Sol J. Barer
(3)
|
| | | | 4,943,664 | | | | | | 7.5 % | | |
Eugene A. Bauer
(4)
|
| | | | 357,816 | | | | | | * | | |
Matthew D. Bayley
(5)(6)
|
| | | | 21,311,586 | | | | | | 31.5 % | | |
Alastair Clemow
(7)
|
| | | | 291,780 | | | | | | * | | |
Michael F. Cola
(8)
|
| | | | 2,994,246 | | | | | | 4.4 % | | |
Barbara G. Duncan
(9)
|
| | | | 200,115 | | | | | | * | | |
Joseph J. Grano, Jr.
(10)
|
| | | | 306,908 | | | | | | * | | |
Garry A. Neil
(11)
|
| | | | 1,893,762 | | | | | | 2.8 % | | |
Michael H. McInaw
(12)
|
| | | | 45,523 | | | | | | * % | | |
All currently-serving directors and executive officers as a group (9 persons)
(13)
|
| | | | 32,345,400 | | | | | | 43.7 % | | |
|
Reverse Stock Split Ratio
|
| |
Approximate Number of Outstanding Shares of Common
Stock Following the Reverse Stock Split |
|
|
1-for-
|
| |
|
|
|
1-for-
|
| |
|
|
|
1-for-
|
| |
|
|
|
1-for-
|
| |
|
|
|
1-for-
|
| |
|
|
1 Year Aevi Genomic Medicine Chart |
1 Month Aevi Genomic Medicine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions